Overview
  • Transaction Name: Novo Nordisk A/S / Dicerna Pharmaceuticals, Inc.
  • Acquirer: Novo Nordisk A/S
  • Target: Dicerna Pharmaceuticals, Inc.
  • Announcement Date: November 18, 2021
  • Status: Pending
Loading...
  • of